GREEN CROSS WellBeing Corporation (KOSDAQ:234690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Prescription Drugs	108.44B	102.95B
Prescription Drugs Growth	5.33%	-
Health Functional Food	26.41B	17.58B
Health Functional Food Growth	50.23%	-
Unallocated Adjutment	-1.05B	-
Total	133.80B	120.53B
Total Growth	11.01%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Overseas	2.12B	590.13M
Overseas Growth	259.37%	-
South Korea	131.68B	119.94B
South Korea Growth	9.79%	-
Total	133.80B	120.53B
Total Growth	11.01%	-

Source: S&P Global Market Intelligence.